TY - JOUR
T1 - Association of vitamin D with incident glaucoma
T2 - Findings from the Women's Health Initiative
AU - Carbone, Laura D.
AU - Johnson, Karen
AU - Larson, Joseph C.
AU - Thomas, Fridtjof
AU - Wactawski-Wende, Jean
AU - Bollinger, Kathryn
AU - Chen, Zhao
AU - Watsky, Mitchell
N1 - Funding Information:
Funding The Women’s Health Initiative (WHI) program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), U.S. Department of Health and Human Services through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C and HHSN271201100004C. Additional funding was supplied by NIH Grant #R01 EY021747 (MAW). JWW-WHI NHLBI support the WHI northeast regional center activities. KB is supported in part by NIH grant R01EY027406.
Publisher Copyright:
© 2021 BMJ Publishing Group. All rights reserved.
PY - 2021/4/1
Y1 - 2021/4/1
N2 - The relationship between vitamin D and glaucoma is controversial. The objective of this study was to examine women from the Women's Health Initiative (WHI) to determine if there is an association between vitamin D and incident glaucoma in postmenopausal women. We examined the association between dietary vitamin D intake, vitamin D supplements and serum 25 hydroxyvitamin D (25(OH)D) levels and the risk of developing glaucoma. 143,389 postmenopausal women from the WHI including a subset with serum 25(OH) D measurements were examined to determine the association of dietary, supplemental and serum levels of vitamin D to the development of glaucoma. Dietary intakes of vitamin D, use of vitamin D supplements and serum levels of 25(OH) D were predictors examined for the main outcome of incident glaucoma. In multivariable models adjusted for demographic, clinical variables and medication use, dietary vitamin D, vitamin D supplements, total vitamin D intake (diet plus supplements) and serum 25 (OH) D measurements were not significantly associated with incident glaucoma. In the CaD placebo-controlled intervention clinical trial, there was also no association in the active intervention arm with glaucoma. We conclude that dietary vitamin D intake, supplements and serum levels are not significantly related to the risk of developing glaucoma in postmenopausal women.
AB - The relationship between vitamin D and glaucoma is controversial. The objective of this study was to examine women from the Women's Health Initiative (WHI) to determine if there is an association between vitamin D and incident glaucoma in postmenopausal women. We examined the association between dietary vitamin D intake, vitamin D supplements and serum 25 hydroxyvitamin D (25(OH)D) levels and the risk of developing glaucoma. 143,389 postmenopausal women from the WHI including a subset with serum 25(OH) D measurements were examined to determine the association of dietary, supplemental and serum levels of vitamin D to the development of glaucoma. Dietary intakes of vitamin D, use of vitamin D supplements and serum levels of 25(OH) D were predictors examined for the main outcome of incident glaucoma. In multivariable models adjusted for demographic, clinical variables and medication use, dietary vitamin D, vitamin D supplements, total vitamin D intake (diet plus supplements) and serum 25 (OH) D measurements were not significantly associated with incident glaucoma. In the CaD placebo-controlled intervention clinical trial, there was also no association in the active intervention arm with glaucoma. We conclude that dietary vitamin D intake, supplements and serum levels are not significantly related to the risk of developing glaucoma in postmenopausal women.
KW - blindness
KW - vitamin D
KW - vitamin D deficiency
UR - http://www.scopus.com/inward/record.url?scp=85099386001&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099386001&partnerID=8YFLogxK
U2 - 10.1136/jim-2020-001645
DO - 10.1136/jim-2020-001645
M3 - Article
C2 - 33431603
AN - SCOPUS:85099386001
VL - 69
SP - 843
EP - 850
JO - Journal of Investigative Medicine
JF - Journal of Investigative Medicine
SN - 1081-5589
IS - 4
ER -